UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 25

Sortiert nach

Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection

The New England journal of medicine, 2013-11, Vol.369 (19), p.1807-1818

2013

Link zum Volltext

Verfügbarkeit prüfen

Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

The Journal of infectious diseases, 2014-08, Vol.210 (3), p.354-362

2014

Link zum Volltext

Verfügbarkeit prüfen

Risk of Developing Specific AIDS-Defining Illnesses in Patients Coinfected with HIV and Hepatitis C Virus With or Without Liver Cirrhosis

Clinical infectious diseases, 2009-08, Vol.49 (4), p.612-622

2009

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort

Journal of acquired immune deficiency syndromes (1999), 2011-10, Vol.58 (2), p.163

2011

Link zum Volltext

Verfügbarkeit prüfen

Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy

American journal of hematology, 2012-08, Vol.87 (8), p.749-753

2012

Link zum Volltext

Verfügbarkeit prüfen

Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy

AIDS (London), 2008-09, Vol.22 (14), p.1769-1778

2008

Link zum Volltext

Verfügbarkeit prüfen

Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER Cohort

Journal of antimicrobial chemotherapy, 2005-07, Vol.56 (1), p.190-195

2005

Link zum Volltext

Verfügbarkeit prüfen

Virological and immunological responses to a once-a-day antiretroviral regimen with didanosine, lamivudine and efavirenz

Antiviral therapy, 2001-12, Vol.6 (4), p.249-253

2001

Link zum Volltext

Verfügbarkeit prüfen

Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients

Journal of acquired immune deficiency syndromes (1999), 2009-08, Vol.51 (5), p.574

2009

Link zum Volltext

Verfügbarkeit prüfen

Key questions in antiretroviral therapy: Italian Consensus Workshop (2005)

Journal of antimicrobial chemotherapy, 2006-06, Vol.57 (6), p.1055-1064

2006

Link zum Volltext

Verfügbarkeit prüfen

Quantification of the impact of HIV-1 reverse transcriptase and protease mutations on the efficacy of rescue HAART

Antiviral research, 2000-02, Vol.45 (2), p.101-114

2000

Link zum Volltext

Verfügbarkeit prüfen

Strategies to decrease viral load rebound, and prevent loss of CD4 and onset of resistance during structured treatment interruptions

Antiviral therapy, 2004-02, Vol.9 (1), p.123-132

2004

Link zum Volltext

Verfügbarkeit prüfen

Different immunologic profiles characterize HIV infection in highly active antiretroviral therapy-treated and antiretroviral-naïve patients with undetectable viraemia

AIDS (London), 2000-01, Vol.14 (2), p.109-116

2000

Link zum Volltext

Verfügbarkeit prüfen

Higher levels of HIV DNA in memory and naive CD4 + T cell subsets of viremic compared to non-viremic patients after 18 and 24 months of HAART

Antiviral research, 2001-06, Vol.50 (3), p.197-206

2001

Link zum Volltext

Verfügbarkeit prüfen

Changes in plasma HIV-RNA and CD4 lymphocyte counts in patients receiving highly active antiretroviral therapy

AIDS (London), 1999-08, Vol.13 (12), p.1594-1595

1999

Link zum Volltext

Verfügbarkeit prüfen

Salvage therapy in HIV-positive patients with a previous therapeutic experience with protease inhibitors

AIDS (London), 1999-08, Vol.13 (12), p.1591-1592

1999

Link zum Volltext

Verfügbarkeit prüfen

European Confederation of Medical Mycology (ECMM) prospective survey of cryptococcosis: Report from Italy

Medical Mycology, 2002, Vol.40 (5), p.507-517

Network, Fimua Cryptococcosis

2002

Link zum Volltext

Verfügbarkeit prüfen

Efavirenz, nelfinavir, and stavudine rescue combination therapy in HIV-1-positive patients heavily pretreated with nucleoside analogues and protease inhibitors

Journal of acquired immune deficiency syndromes (1999), 1999-12, Vol.22 (5), p.453

1999

Link zum Volltext

Verfügbarkeit prüfen

Effects of Subinhibitory Concentrations of Moxifloxacin in an In-Vitro Dynamic Model

Journal of chemotherapy (Florence), 2000-04, Vol.12 (2), p.129-133

2000

Link zum Volltext

Verfügbarkeit prüfen

In-Vitro Activity of Moxifloxacin Combined with Other Antibacterials Against Methicillin-Resistant Staphylococcus aureus

Journal of chemotherapy (Florence), 2000-06, Vol.12 (3), p.195-198

2000

Link zum Volltext

Verfügbarkeit prüfen

Abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-positive patients

AIDS (London), 2002-09, Vol.16 (14), p.1981-1981

2002

Link zum Volltext

Verfügbarkeit prüfen

Higher short-term virologic efficacy of three-class versus two-class highly active antiretroviral salvage therapy in HIV-infected patients

European journal of clinical microbiology & infectious diseases, 2000-05, Vol.19 (5), p.380-384

2000

Link zum Volltext

Verfügbarkeit prüfen

Etofenamate and transcutaneous electrical nerve stimulation treatment of painful spinal syndromes

International journal of clinical pharmacology research, 1988, Vol.8 (4), p.295

1988

Link zum Volltext

Verfügbarkeit prüfen

Elevated concentrations of plasma α-melanocyte stimulating hormone are associated with reduced disease progression in HIV-infected patients

The Journal of laboratory and clinical medicine, 1999-03, Vol.133 (3), p.309-315

1999

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 25

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(25)

Sprache

Englisch
(25)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(25)
Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Infectious Diseases
(22)
Humans
(21)
Pharmacology. Drug Treatments
(18)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(16)
Female
(16)
Male
(16)
Hiv Infections - Drug Therapy
(14)
Adult
(13)
Virology
(13)
Antiviral Agents
(12)
Anti-Hiv Agents - Therapeutic Use
(11)
Human Immunodeficiency Virus
(11)
Immunology
(10)
Drug Therapy, Combination
(9)
Hiv
(9)
Hiv Infections - Virology
(9)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection

Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

Risk of Developing Specific AIDS-Defining Illnesses in Patients Coinfected with HIV and Hepatitis C Virus With or Without Liver Cirrhosis

Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort

Durability of lopinavir/ritonavir monotherapy in individuals with viral load ≤50 copies/ml in an observational setting

Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy

Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy

Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER Cohort

Virological and immunological responses to a once-a-day antiretroviral regimen with didanosine, lamivudine and efavirenz

Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients

Key questions in antiretroviral therapy: Italian Consensus Workshop (2005)

Quantification of the impact of HIV-1 reverse transcriptase and protease mutations on the efficacy of rescue HAART

Strategies to decrease viral load rebound, and prevent loss of CD4 and onset of resistance during structured treatment interruptions

Different immunologic profiles characterize HIV infection in highly active antiretroviral therapy-treated and antiretroviral-naïve patients with undetectable viraemia

Higher levels of HIV DNA in memory and naive CD4 + T cell subsets of viremic compared to non-viremic patients after 18 and 24 months of HAART

Changes in plasma HIV-RNA and CD4 lymphocyte counts in patients receiving highly active antiretroviral therapy

Salvage therapy in HIV-positive patients with a previous therapeutic experience with protease inhibitors

European Confederation of Medical Mycology (ECMM) prospective survey of cryptococcosis: Report from Italy

Efavirenz, nelfinavir, and stavudine rescue combination therapy in HIV-1-positive patients heavily pretreated with nucleoside analogues and protease inhibitors

Effects of Subinhibitory Concentrations of Moxifloxacin in an In-Vitro Dynamic Model

In-Vitro Activity of Moxifloxacin Combined with Other Antibacterials Against Methicillin-Resistant Staphylococcus aureus

Abacavir-based triple nucleoside therapy versus continued protease inhibitor-based highly active antiretroviral therapy in HIV-1-positive patients

Higher short-term virologic efficacy of three-class versus two-class highly active antiretroviral salvage therapy in HIV-infected patients

Etofenamate and transcutaneous electrical nerve stimulation treatment of painful spinal syndromes

Elevated concentrations of plasma α-melanocyte stimulating hormone are associated with reduced disease progression in HIV-infected patients

Aktive Filter

Suchergebnisse filtern